StockNews.AI
CRAI
StockNews.AI
40 days

Charles River Associates (CRA) Expands Its Transfer Pricing Practice

1. Dr. Gene Tien joins CRA as VP in Transfer Pricing Practice. 2. His expertise will deepen CRA's capabilities in tax strategy. 3. Tien has extensive experience with multinational clients on pricing. 4. He provides practical advice on complex transfer pricing issues. 5. CRA aims to enhance its competitive edge in consulting services.

6m saved
Insight
Article

FAQ

Why Bullish?

The addition of Dr. Tien indicates an expansion of CRA's service capabilities. Historical growth following key hires supports a positive outlook.

How important is it?

The appointment is significant for long-term growth and competitive positioning, impacting future revenues positively.

Why Long Term?

Tightening expertise in transfer pricing may drive client retention and acquisition over time, solidifying CRA's market position.

Related Companies

TAXKPMGDeloitte
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Dr. Gene Tien has joined CRA as a vice president in the Transfer Pricing Practice. "We are pleased to welcome Gene to our team," said Paul Maleh, President and Chief Executive Officer of Charles River Associates. "Gene's extensive expertise in transfer pricing and his ability to provide strategic advice to multinational clients will be invaluable in deepening our capabilities in this critical area." Rebel Curd, Practice Leader of the Transfer Pricing Practice, added, "Gene's understanding of intercompany pricing and his innovative approach to solving complex tax issues will be a tremendous asset to our clients. We are excited to have him on board and look forward to the contributions he will make to our practice." Dr. Tien brings extensive experience in working with global multinationals on intercompany pricing and economic valuation issues that impact their most relevant tax positions, providing practical, commercial advice to multinationals to address their intercompany pricing needs. His prior client matters have included designing and implementing global pricing strategies related to intellectual property and value-creating activities; assessing risk from a holistic transfer pricing and tax perspective; and leading global audit defense and dispute resolution matters. Dr. Tien brings broad-based industry experience, including in the digital economy, pharmaceutical, scientific instrumentation, medical device, retail, oilfield/natural resource service, and branded consumer product goods sectors. Dr. Tien regularly presents and writes on international transfer pricing policy trends. He holds a Ph.D. in Economics from Northwestern University. About CRA’s Transfer Pricing Practice CRA’s Transfer Pricing Practice offers comprehensive, world-class functional, industry, and international expertise combined with rigorous economic and financial analysis to companies in all industries. Clients turn to CRA for the perspective and diverse set of skills required to assist in every phase of the tax cycle, including planning, documentation, and tax valuation. CRA’s experts also provide audit defense and support in litigation and alternative dispute resolution. About Charles River Associates (CRA) Charles River Associates® is a leading global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at www.crai.com. Follow us on LinkedIn, Instagram, and Facebook. SAFE HARBOR STATEMENT Statements in this press release concerning the addition of Gene Tien and the expanding, contributing to, and deepening the capabilities of CRA’s Transfer Pricing Practice, and any future business Dr. Tien may generate for CRA, are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management’s current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by CRA include, among others: the failure to generate engagements for us; the potential loss of clients; the demand environment; global economic conditions; foreign exchange rate fluctuations; and intense competition. Additional potential factors that could affect our financial results are included in our periodic filings with the Securities and Exchange Commission, including those under the heading “Risk Factors.” We cannot guarantee any future results, levels of activity, performance, or achievement. We undertake no obligation to update any forward-looking statements after the date of this press release, and we do not intend to do so.

Related News